The Mechanism by Which Cyperus rotundus Ameliorates Osteoarthritis: A Work Based on Network Pharmacology
Min-Dong Du,Kai-Yi He,Si-Qi Fan,Jin-Yi Li,Jin-Fu Liu,Zi-Qiang Lei,Gang Qin
DOI: https://doi.org/10.2147/jir.s483652
IF: 4.5
2024-10-29
Journal of Inflammation Research
Abstract:Min-Dong Du, 1, 2, &ast Kai-Yi He, 3, &ast Si-Qi Fan, 3 Jin-Yi Li, 3 Jin-Fu Liu, 3 Zi-Qiang Lei, 3 Gang Qin 3 1 Department of Osteoarthrosis, Xing-An Jieshou Orthopedics Hospital, Guilin, People's Republic of China; 2 Department of Orthopaedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China; 3 Department of Osteoarthrosis, The First Affiliated Hospital of Guangxi Traditional Chinese Medical University, Nanning, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gang Qin, Department of Osteoarthrosis, The First Affiliated Hospital of Guangxi Traditional Chinese Medical University, 89-9 Dongge Road, Nanning, Guangxi, 530023, People's Republic of China, Tel +86-771-5361264, Email Background: Cyperus rotundus (CR) is widely used in traditional Chinese medicine to prevent and treat a variety of diseases. However, its functions and mechanism of action in osteoarthritis (OA) has not been elucidated. Here, a comprehensive strategy combining network pharmacology, molecular docking, molecular dynamics simulation and in vitro experiments was used to address this issue. Methods: The bioactive ingredients of CR were screened in TCMSP database, and the potential targets of these ingredients were obtained through Swiss Target Prediction database. Genes in OA pathogenesis were collected through GeneCards, OMIM and DisGeNET databases. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed using DAVID database. STRING database and Cytoscape 3.10 software were used to construct "component-target-pathway" network, and predict the core targets affected by CR. The binding affinity between bioactive components and the core targets was evaluated by molecular docking and molecular dynamics simulation. The therapeutic activity of kaempferol on chondrocytes in inflammatory conditions was verified by in vitro experiments. Results: Fifteen CR bioactive ingredients were obtained, targeting 192 OA-related genes. A series of biological processes, cell components, molecular functions and pathways were predicted to be modulated by CR components. The core targets of CR in OA treatment were AKT serine/threonine kinase 1 (AKT1), interleukin 1 beta (IL1B), SRC proto-oncogene, non-receptor tyrosine kinase (SRC), BCL2 apoptosis regulator (BCL2), signal transducer and activator of transcription 3 (STAT3), epidermal growth factor receptor (EGFR), hypoxia-inducible factor 1 subunit alpha (HIF1A), matrix metallopeptidase 9 (MMP9), estrogen receptor 1 (ESR1) and PPARG orthologs from vertebrates (PPARG), and the main bioactive ingredients of CR showed good binding affinity with these targets. In addition, kaempferol, one of the CR bioactive components, weakens the effects of IL-1β on the viability, apoptosis and inflammation of chondrocytes. Conclusion: Theoretically, CR has great potential to ameliorate the symptoms and progression of OA, via multiple components, multiple targets, and multiple downstream pathways. Keywords: osteoarthritis, Cyperus rotundus , network pharmacology, molecular docking Graphical Osteoarthritis (OA) is a common degenerative joint disease, mainly characterized by articular cartilage injury, subchondral osteosclerosis and synovial tissue inflammation. 1,2 Aging, joint trauma and obesity are important risk factors for the pathogenesis of OA. 3 In recent years, the prevalence of OA has gradually increased. 4,5 Epidemiological surveys show that OA affects about 260 million people worldwide, 6 accounting for 2.4% of the total number of people with disabilities. 3,5 At present, the clinical treatment of OA mainly uses non-steroidal anti-inflammatory drugs or intra-articular local injection of glucocorticoid to reduce symptoms and restore joint function. 7 However, long-term use of these drugs leads to side effects associated with gastrointestinal, kidney, and cardiovascular symptoms. 8 Therefore, there is an urgent need to develop effective treatments with better bioavailability and less systemic toxicity. It is important to note that the pathogenesis of human disease is often associated with abnormalities in multiple genes, proteins and pathways. Specifically, in OA, multiple pathways related to chondrocyte injury, inflammatory response, and extracellular matrix synthesis are dysregulated, and these pathways have synergistic effects in the occurrence and progression of OA, and also cause the diversification of clinical -Abstract Truncated-
immunology